Atezolizumab,Bevacizumab,Sorafenib
Bayer,Roche
[]
bringing immunotherapy into the adjuvant setting for hcc. look forward to seeing the data!
#gi23 #hcc 
GI #Oncologist @ClevelandClinic | @USNews contributor | Tweets my own